Two Sigma Investments’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,082	Closed	-$371K	–	2846
2020 Q4	$371K	Sell	16,082 -28,331	-64%	-$654K	﹤0.01%	1668
2020 Q3	$452K	Buy	44,413 +21,149	+91%	+$215K	﹤0.01%	1458
2020 Q2	$347K	Buy	23,264 +2,953	+15%	+$44K	﹤0.01%	1564
2020 Q1	$248K	Buy	+20,311	New	+$248K	﹤0.01%	1525